SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898432-08-000608
Filing Date
2008-06-26
Accepted
2008-06-26 16:52:36
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 sc13d.htm SC 13D 100408
  Complete submission text file 0000898432-08-000608.txt   102581
Mailing Address 2000 POWELL STREET, SUITE 800 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 800 EMERYVILLE CA 94608 510-595-6000
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (Subject) CIK: 0000918112 (see all company filings)

IRS No.: 943049219 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-49135 | Film No.: 08919867
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice